Resveratrol Reverses Hydrogen Peroxide-induced Proliferative Effects in Human Coronary Smooth Muscle Cells: A Novel Signaling Mechanism

Archives of Medical Research

Volumn 39, Issue 2, 2008, Pages 155-161

  El Mowafy, Abdalla M ^a   Alkhalaf, Moussa ^c   El Kashef, Hassan A ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b University of Mansoura   (Egypt)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Atherogenesis; cGMP; ERK1 2; Human coronary arteries; Reactive oxygen species; Resveratrol

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; HYDROGEN PEROXIDE; ISOBUTYLMETHYLXANTHINE; KT 5720; KT 5823; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHODIESTERASE INHIBITOR; REACTIVE OXYGEN METABOLITE; RESVERATROL;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CYCLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVATION; ENZYME INHIBITION; HEART PROTECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANTIOXIDANTS; CELL LINE; CELL PROLIFERATION; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; HYDROGEN PEROXIDE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, SMOOTH MUSCLE; OXIDANTS; PROTEIN KINASE INHIBITORS; STILBENES;

EID: 37349064416     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.09.010     Document Type: Article

References (45)

1. Vaziri N.D., and Rodriguez-Iturbe B. Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2 (2006) 582-593
2. Gutierrez J., Ballinger S.W., Darley-Usmar V.M., and Landar A. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res 99 (2006) 924-932
3. Brown D.R. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defense. Folia Neuropathol 43 (2005) 229-243
4. Wright Jr. E., Scism-Bacon J.L., and Glass L.C. Oxidative stress in type-2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 60 (2006) 308-314
5. Sandberg E.M., and Sayeski P.P. Jak2 tyrosine kinase mediates oxidative stress-induced apoptosis in vascular smooth muscle cells. J Biol Chem 279 (2004) 34547-3452
6. Kim J., Min G., Bae Y.S., and Min D.S. Phospholipase-D is involved in oxidative stress-induced migration of vascular smooth-muscle cells via tyrosine phosphorylation and protein kinase-C. Exp Mol Med 36 (2004) 103-109
7. Chan W.H., Wu H.J., and Shiao N.H. Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal-kinase, caspase-3, and p21-activated kinase-2. J Cell Biochem 100 (2007) 1056-1069
8. Davis R.J. MAPKs: new JNK expands the group. Trends Biochem Sci 19 (1994) 470-473
9. Knight R.J., and Buxton D.B. Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem Biophys Res Commun 218 (1996) 83-88
10. De Silva H., Cioffi C., Yin T., Sandhu G., Webb R.L., and Whelan J. Identification of a novel stress activated kinase in kidney and heart. Biochem Biophys Res Commun 250 (1998) 647-652
11. Gille H., Sharrocks A.D., and Shaw P.E. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358 (1992) 414-417
12. Cavigelli M., Dolfi F., Claret F.X., and Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J 14 (1995) 5957-5964
13. Jin N., Siddiqu R.A., English D., and Rhoades R.A. Communication between tyrosine-kinase pathway and myosin-light-chain-kinase pathway in smooth muscle. Am J Physiol 271 (1996) H1348-H1355
14. Florian J.A., and Watts S.W. Integration of mitogen-activated protein kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction. J Pharmacol Exp Ther 284 (1998) 346-355
15. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?. Eur J Endocrinol 138 (1998) 619-620
16. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
17. Kar P., Laight D., Shaw K.M., and Cummings M.H. Flavonoid-rich grapeseed extracts: a new approach in high cardiovascular risk patients?. Int. J Clin Pract 60 (2006) 1484-1492
18. Fitzpatrick D.F., Hirschfield S.L., and Coffey R.G. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265 (1993) H774-H778
19. Chen C.K., and Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 27 (1996) 363-366
20. El-Mowafy A.M. Resveratrol activates guanylyl-cyclase in coronary arterial smooth muscle: a novel signaling mechanism in support of coronary protection. Biochem Biophys Res Commun 291 (2002) 1218-1224
21. A- and cyclooxygenase-dependent mechanism. Br J Pharmacol 118 (1996) 531-536
22. El-Mowafy A.M., and Alkhalaf M. Resveratrol activates adenylyl-cyclase in human breast-cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 24 (2003) 869-873
23. El-Mowafy A.M., and White R.E. Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects. FEBS Lett 451 (1999) 63-67
24. Potter L.R., and Hunter T. Activation of protein kinase-C stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue, a possible mechanism of heterologous desensitization. J Biol Chem 275 (2000) 31099-31106
25. Griendling K.K., and FitzGerald G.A. Oxidative stress and cardiovascular injury. II: Animal and human studies. Circulation 108 (2003) 2034-2040
26. Boullier A., Bird D.A., Chang M.K., Dennis E.A., Friedman P., Gillotre-Taylor K., et al. Scavenger receptors, oxidized-LDL, and atherosclerosis. Ann NY Acad Sci 947 (2001) 214-222
27. Taniyama Y., and Griendling K.K. Reactive oxygen species in the vasculature: Molecular and cellular mechanisms. Hypertension 42 (2003) 1075-1081
28. +-channel-mediated vasodilation. Vascul Pharmacol 38 (2002) 43-49
29. +-channel activity in smooth muscle of human coronary arterioles. Circ Res 91 (2002) 1070-1076
30. 2 elevated by oxidized LDL enhances human aortic smooth muscle cell proliferation. J Biomed Sci 14 (2007) 245-254
31. Valentin F., Bueb J.L., Kieffer P., Tschirhart E., and Atkinson J. Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells. Fundam Clin Pharmacol 19 (2005) 661-667
32. Yasunari K., Maeda K., Nakamura M., and Yoshikawa J. Pressure promotes angiotensin II-mediated migration of human coronary smooth muscle cells through increase in oxidative stress. Hypertension 39 2 Pt 2 (2002) 433-437
33. Poussier B., Cordova A.C., Becquemin J.-P., and Sumpio B.E. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg 42 (2005) 1190-1198
34. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart I., Park J., Schulz S., et al. Guanylyl-cyclases and signaling by cyclic-GMP. Pharmacol Rev 52 (2000) 375-414
35. Soderling S.H., and Beavo J.A. Regulation of cAMP and cGMP signaling, new phosphodiesterases and new functions. Curr Opin Cell Biol 12 (2000) 174-179
36. Zou J., Huang Y., Chen Q., Wang N., Cao K., Hsieh T.C., et al. Suppression of mitogenesis and regulation of cell-cycle traverse by resveratrol in cultured smooth-muscle cells. Int J Oncol 15 (1999) 647-651
37. Lee J., Kang D.G., Kook H., Kim I.K., and Oh B.K. Differentially-altered vascular guanylate-cyclase isoforms in experimental hypertensive rats. J Korean Med Sci 14 (1999) 386-392
38. Arjona A.A., Hsu C.A., Wrenn D.S., and Hill N.S. Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds. Gen Pharmacol 28 (1997) 387-392
39. Mizutani K., Ikeda K., Kawai Y., and Yamori Y. Extract of wine phenolics improves aortic biomechanical properties in stroke-prone spontaneously hypertensive rats (SHRSP). J Nutr Sci Vitaminol 45 (1999) 95-106
40. Hamad A.M., and Knox A.J. Mechanisms involved in desensitization of particulate guanylyl-cyclase in human airway smooth muscle, the role of protein kinase-C. Biochem Biophys Res Commun 266 (1999) 152-155
41. Alfonzo M.J., de Becemberg I.L., de Villaroel S.S., de Herrera V.N., Misle A.J., and de Alfonzo R.G. Two opposite signal transducing mechanisms regulate a G-protein-coupled guanylyl-cyclase. Arch Biochem Biophys 1350 (1998) 19-25
42. Wang Z., Chen Y., Labinskyy N., Hsieh T.C., Ungvari Z., and Wu J.M. Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts. Biochem Biophys Res Commun 346 (2006) 367-376
43. Chao H.H., Juan S.H., Liu J.C., Yang H.Y., Yang E., Cheng T.H., et al. Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells. Eur J Pharmacol 515 (2005) 1-9
44. Lee B., and Moon S.K. Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J Nutr 135 (2005) 2767-2773
45. Bertelli A., Bertelli A.A., Gozzini A., and Giovannini L. Plasma tissue resveratrol concentrations pharmacological activity. Drugs Exp Clin Res 24 (1998) 133-138